Your browser doesn't support javascript.
loading
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study.
Cianflone, Francesco; Lazarevic, Dejan; Palmisano, Anna; Fallara, Giuseppe; Larcher, Alessandro; Freschi, Massimo; Dell'Antonio, Giacomo; Scotti, Giulia Maria; Morelli, Marco J; Ferrara, Anna Maria; Trevisani, Francesco; Cinque, Alessandra; Esposito, Antonio; Briganti, Alberto; Tacchetti, Carlo; Doglioni, Claudio; Del Maschio, Alessandro; de Cobelli, Francesco; Bertini, Roberto; Salonia, Andrea; Montorsi, Francesco; Tonon, Giovanni; Capitanio, Umberto.
Afiliação
  • Cianflone F; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Lazarevic D; Center for Omics Scences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Palmisano A; Department of Radiology, Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Fallara G; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Larcher A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Freschi M; Department of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Dell'Antonio G; Department of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Scotti GM; Center for Omics Scences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Morelli MJ; Center for Omics Scences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ferrara AM; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Trevisani F; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Cinque A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Esposito A; Department of Radiology, Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Briganti A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Tacchetti C; Unit of Cancer Imaging, Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Doglioni C; Department of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Del Maschio A; Department of Radiology, Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • de Cobelli F; Department of Radiology, Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Bertini R; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Salonia A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Montorsi F; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Tonon G; Center for Omics Scences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Capitanio U; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Transl Androl Urol ; 11(2): 149-158, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35280651
Background: The combination of radiomic and transcriptomic approaches for patients diagnosed with small clear-cell renal cell carcinoma (ccRCC) might improve decision making. In this pilot and methodological study, we investigate whether imaging features obtained from computed tomography (CT) may correlate with gene expression patterns in ccRCC patients. Methods: Samples from 6 patients who underwent partial nephrectomy for unilateral non-metastatic ccRCC were included in this pilot cohort. Transcriptomic analysis was conducted through RNA-sequencing on tumor samples, while radiologic features were obtained from pre-operative 4-phase contrast-enhanced CT. To evaluate the heterogeneity of the transcriptome, after a 1,000 re-sampling via bootstrapping, a first Principal Component Analyses (PCA) were fitted with all transcripts and a second ones with transcripts deriving from a list of 369 genes known to be associated with ccRCC from The Cancer Genome Atlas (TCGA). Significant pathways in each Principal Components for the 50 genes with the highest loadings absolute values were assessed with pathways enrichment analysis. In addition, Pearson's correlation coefficients among radiomic features themselves and between radiomic features and transcripts expression values were computed. Results: The transcriptomes of the analysed samples showed a high grade of heterogeneity. However, we found four radiogenomic patterns, in which the correlation between radiomic features and transcripts were statistically significant. Conclusions: We showed that radiogenomic approach is feasible, however its clinical meaning should be further investigated.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Transl Androl Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Transl Androl Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: China